Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Cytori Therapeutics Inc    CYTX

Delayed Quote. Delayed  - 04/29 09:59:48 pm
0.32 USD   -5.88%
04/29 CYTORI THERAPEU : to Webcast First Quarter Financial Results on May ..
04/27 CYTORI THERAPEU : Announces Timing for Full Enrollment in U.S. Phase..
04/18 CYTORI THERAPEU : Strengthens Global Patent Portfolio
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/25/2016 04/26/2016 04/27/2016 04/28/2016 04/29/2016 Date
0.3229(c) 0.3373(c) 0.35(c) 0.34(c) 0.32(c) Last
2 889 020 4 653 205 4 629 989 3 231 974 3 007 773 Volume
+8.98% +4.46% +3.77% -2.86% -5.88% Change
More quotes
Financials ($)
Sales 2016 11,0 M
EBIT 2016 -20,7 M
Net income 2016 -22,7 M
Debt 2016 -
Yield 2016 -
Sales 2017 18,1 M
EBIT 2017 -18,6 M
Net income 2017 -19,9 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 5,77x
Capi. / Sales 2017 3,49x
Capitalization 63,3 M
More Financials
Company
Cytori Therapeutics, Inc. is a late stage cell therapy company.Its develops autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy™ acts principally... 
More about the company
Surperformance© ratings of Cytori Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on CYTORI THERAPEUTICS INC
04/29 CYTORI THERAPEUTICS : to Webcast First Quarter Financial Results on May 10
04/28 CYTORI THERAPEUTICS : Strengthens Global Patent Portfolio
04/27 CYTORI THERAPEUTICS : Announces Timing for Full Enrollment in U.S. Phase III Scl..
04/21 CYTORI THERAPEUTICS : to Present Preliminary Safety and Efficacy Preclinical Dat..
04/18 CYTORI THERAPEUTICS : Strengthens Global Patent Portfolio
04/14 CYTORI THERAPEUTICS : Trademark Application for "STEMSOURCE" Filed by Cytori The..
04/14 CYTORI THERAPEUTICS : to Present Preliminary Safety and Efficacy Preclinical Dat..
04/06 CYTORI THERAPEUTICS : 2016 Investors Note
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
04/29 ST JUDE MEDICAL : Abbott is counting on growth turnaround at St. Jude Medical
04/29 ABBOTT LABORATORIES : buys St. Jude Medical for $19.3 billion
04/29 CORRECTION : Abbott-St Jude Acquisition story
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
03/24 Cytori's late-stage study of ECCS-50 in scleroderma 50% enrolled; study to co..
03/04 Cytori Therapeutics reports Q4 and FY15 results
03/04 Cytori Therapeutics' (CYTX) CEO Marc Hedrick on Q4 2015 Results - Earnings Ca..
03/03 Cytori Therapeutics beats by $0.01, misses on revenue
03/02 Notable earnings after Thursday?s close


Comments 
Advertisement
Chart CYTORI THERAPEUTICS INC
Duration : Period :
Cytori Therapeutics Inc Technical Analysis Chart | CYTX | US23283K1051 | 4-Traders
Full-screen chart
Technical analysis trends CYTORI THERAPEUTI...
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions